Abstract
Transcription is considered to be a crucial step in the replication cycle of HIV-1. Tat regulates an early step of transcription elongation. The positive elongation factor P-TEFb, a heterodimer containing a catalytic subunit (CDK9) and unique regulatory cyclins (CycT1), is required for HIV-1 Tat transcriptional activation. This is a potential target for new HIV-1 transcription inhibitors. Without P-TEFb, transactivation is restrained and only short transcripts are generated. All the P-TEFb inhibitors can suppress the HIV-1 transactivation process by inhibition of CycT1, CDK9 or their interaction. Several low-molecular-weight compounds such as flavopiridol, roscovitine and the human small nuclear RNA 7SK which have been showed to possess potent anti-HIV activity by interfering with P-TEFb functions are reviewed in this article.
MeSH terms
-
Flavonoids / chemistry
-
Flavonoids / pharmacology
-
HIV Infections / drug therapy*
-
HIV Infections / metabolism
-
HIV Infections / virology
-
HIV-1 / drug effects*
-
HIV-1 / physiology*
-
Humans
-
Models, Biological
-
Piperidines / chemistry
-
Piperidines / pharmacology
-
Positive Transcriptional Elongation Factor B / antagonists & inhibitors*
-
Positive Transcriptional Elongation Factor B / chemistry
-
Positive Transcriptional Elongation Factor B / physiology*
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / pharmacology
-
Purines / chemistry
-
Purines / pharmacology
-
RNA, Small Nuclear / chemistry
-
RNA, Small Nuclear / pharmacology
-
Roscovitine
-
Transcription, Genetic / drug effects
-
Transcription, Genetic / physiology
Substances
-
Flavonoids
-
Piperidines
-
Protein Kinase Inhibitors
-
Purines
-
RNA, Small Nuclear
-
Roscovitine
-
alvocidib
-
Positive Transcriptional Elongation Factor B